This is start to smell like cash positive September quarter Trade +receivable $3.480 m Cash in bank $ 880 k Tax credit $ 650 k Total $5.010 m This is company numbers Emil
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%